Rakotonirina 2008.
Clinical features and settings |
Presenting signs and symptoms: Fever over 37.5 °C or history of fever in the previous 24 h Previous treatment for malaria: Participants with recent antimalarial use were not excluded from the study; 34% of participants declared antimalarial use Clinical setting: Two primary health centres Country: Madagascar (Tsiroanomandidy on the west foothill areas of the Highlands) Malaria endemicity: Low and predominantly seasonal Malaria endemic species:P. falciparum (80%) andP. vivax |
|
Participants |
Sample size: 313 Age: All age groups were eligible for inclusion; the actual age range of the included participants was 6 months to 79 years (median age 10 years) Sex: Male: Famale ratio was 1.2:1 Co‐morbidities and pregnancy: Pregnant women were excluded, as were people with signs of severe or complicated malaria Parasite density of microscopy positive cases: Range 32 to 52,750 parasites per μl, mean 4104, Standard Deviation 7894 |
|
Study design | Enrolment was consecutive and prospective. Two RDTs were evaluated; all participants received both RDTs. | |
Target condition and reference standard(s) |
Target condition: Malaria parasitaemia Reference standard: PCR |
|
Index and comparator tests |
Commerical name of RDT: OptiMAL‐IT (DiaMed AG, Cressier, Switzerland) PALUTOP Parasite(s) designed to detect: OptiMAL‐IT ‐ P. falciparum or mixed infection, non‐falciparum species only PALUTOP ‐ P. falciparum, P.vivax and other malaria types Designated Type: OptiMAL‐IT ‐ Type 4 PALUTOP ‐ Type 6 Batch numbers: OptiMAL‐IT ‐ 46110.85.01 PALUTOP ‐ 91014 Transport and storage conditions: Transported and maintained at the study sites (primary health centres) at room temperature and opened just before use to avoid humidity damage Person(s) performing RDT: Trained technician RDT setting: Primary health centres |
|
Follow‐up | Not applicable | |
Notes | Source of funding: Global Fund Project for Madagascar, Round 3 | |
Table of Methodological Quality | ||
Item | Authors' judgement | Description |
Representative spectrum? All tests | Yes | Participants were a consecutive sample of patients attending primary health centres with fever or history of fever in the previous 24 h |
Acceptable reference standard? All tests | Yes | Reference standard was PCR |
Partial verification avoided? All tests | Yes | All participants who received the index test also received the reference test |
Differential verification avoided? All tests | Yes | The same reference test was used regardless of the index test results |
Incorporation avoided? All tests | Yes | The index test does not form part of the reference standard |
Reference standard results blinded? All tests | Yes | Stated that the PCR operator was blind to the results of the other tests performed |
Index test results blinded? All tests | Yes | Stated that the test readers were blind to the results of the other tests performed |
Uninterpretable results reported? All tests | Yes | There were no test failures with either RDT |
Withdrawals explained? All tests | Yes | The number of participants enrolled in the study is clearly stated and corresponds to the number presented in the analysis |